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Abstract: We report our findings for a patient with orbital apex syndrome associated with 
herpes zoster ophthalmicus. Our patient was initially admitted to a neighborhood hospital 
because of nausea and loss of appetite of 10 days’ duration. The day after hospitalization, she 
developed skin vesicles along the first division of the trigeminal nerve, with severe lid swell-
ing and conjunctival injection. On suspicion of meningoencephalitis caused by varicella zoster 
virus, antiviral therapy with vidarabine and betamethasone was started. Seventeen days later, 
complete ptosis and ophthalmoplegia developed in the right eye. The light reflex in the right eye 
was absent and anisocoria was present, with the right pupil larger than the left. Fat-suppressed 
enhanced T1-weighted magnetic resonance images showed high intensity areas in the muscle 
cone, cavernous sinus, and orbital optic nerve sheath. Our patient was diagnosed with orbital 
apex syndrome, and because of skin vesicles in the first division of the trigeminal nerve, the 
orbital apex syndrome was considered to be caused by herpes zoster ophthalmicus. After the 
patient was transferred to our hospital, prednisolone 60 mg and vidarabine antiviral therapy was 
started, and fever and headaches disappeared five days later. The ophthalmoplegia and optic 
neuritis, but not the anisocoria, gradually resolved during tapering of oral therapy. From the 
clinical findings and course, the cause of the orbital apex syndrome was most likely invasion of 
the orbital apex and cavernous sinus by the herpes virus through the trigeminal nerve ganglia.
Keywords: varicella zoster virus, orbital apex syndrome, herpes zoster ophthalmicus, complete 
ophthalmoplegia
Introduction
Orbital apex syndrome is a condition in which the oculomotor nerve, trochlear 
nerve, abducens nerve, and ophthalmic branch of the trigeminal nerve are damaged. 
These alterations are generally associated with optic nerve dysfunction. Orbital apex 
syndrome can be caused by a variety of inflammatory, infectious, neoplastic, iatrogenic/
traumatic, and vascular conditions.1 We present our findings in a patient with orbital apex 
syndrome associated with herpes zoster ophthalmicus. Magnetic resonance imaging (MRI) 
showed inflammatory changes that extended to the cavernous sinus and orbital apex. Treat-
ment with intravenous prednisolone 60 mg followed by tapering and vidarabine antiviral 
therapy markedly improved the extraocular palsies and optic nerve dysfunction. These 
changes normalized after treatment, which indicated the pathogenesis of the case.
Case report
An 81-year-old woman attended a neighborhood hospital because of nausea and loss 
of appetite of 10 days’ duration. The internist found that the patient was severely 
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dehydrated, and she was admitted to our hospital on the 
same day. On the following day, a rash developed along the 
first division of the trigeminal nerve, and she had a fever of 
about 38°C. No neck stiffness was reported.
Examination of the cerebrospinal fluid showed 90 cells/µL, 
with a predominance of lymphocytes and a protein level of 
75 mg/dL. IgG for varicella zoster virus in the cerebrospinal 
fluid was positive on enzyme immunoassay and the unit value 
was 12.8, but IgM for varicella zoster virus was negative. 
MRI and computed tomographic images of the head showed 
no signs of meningitis or edematous changes in the cerebral 
parenchyma.
Herpetic encephalitis induced by varicella zoster virus 
was suspected from the clinical findings, so intravenous 
vidarabine 600 mg/day was initiated in combination with 
  sulbactam + defoperazone sodium and betamethasone 4 mg. 
The patient still had severe dehydration due to   insufficient 
fluid intake, and her serum creatinine was elevated to 
0.96 mg/dL (normal range 0.47–0.79 mg/dL). Thus, we did 
not use acyclovir systemically because it could have worsened 
her renal dysfunction. However, the headache and orbital pain 
worsened. On day 7 of her hospital stay, there was a reduc-
tion of the corneal reflex, and herpes keratoconjunctivitis 
was diagnosed. Treatment with antiviral ointment, acyclovir, 
and betamethasone eye drops were started. On day 17 of the 
hospital day, she developed ptosis and total ophthalmoplegia 
in the right eye (Figure 1A). The pupillary diameters were 
4.5 mm OD and 2.5 mm OS, and the light reflex in the right 
eye was absent (Figure 1B). The anisocoria was pronounced 
under ordinary room light. Best-corrected visual acuity was 
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Figure 1 Photographs of eye positions in all directions, and the pupils and face of our patient before treatment. (A) Photographs of eye positions in all directions. Complete 
ophthalmoplegia and ptosis can be seen on the right side. (B) Photographs of pupils under standard room lighting. Anisocoria can be seen and the right pupil is dilated. The 
light reflex is absent. (C) Photograph of the face. Mixed vesicular and crusted eruptions can be seen along the first division of the trigeminal nerve. Complete ptosis is present 
in the right eye. (D) Goldmann kinetic perimetry. Slight constriction of the visual field was detected in the right eye.
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0.5 OD and 1.0 OS. Central critical fusion frequency was 
29 Hz OD and 31 Hz OS, and the intraocular pressures 
were 17 mmHg OD and 14 mmHg OS. Goldmann kinetic 
perimetry showed a slight constriction of the central visual 
field in the right eye (Figure 1D). Enhanced T1-weighted 
MRI showed enhancement of the optic nerve and orbital 
apex (Figure 2A and B).
From these clinical findings, ie, orbital inflammation 
affecting the orbital apex and IgG for varicella zoster virus in 
the cerebrospinal fluid, the patient was diagnosed with orbital 
apex syndrome due to varicella zoster virus reactivation.2 
After the patient was transferred to our hospital for further 
treatment, intravenous prednisolone 60 mg/day was started in 
combination with vidarabine 600 mg/day. The ocular symptoms 
improved soon after initiation of steroid therapy. The limitation 
of adduction and supraduction improved from day 1 after 
initiation of therapy. Repeated MRI showed a decrease in 
enhancement of the right optic nerve and the tissues around 
the orbital apex (Figure 2C and D). Levels of cells and proteins 
in the cerebrospinal fluid were also decreased. The ptosis had 
recovered by about 11 weeks after the start of   treatment. The 
right palpebral fissure was 9 mm and levator function was 
10 mm. Twelve weeks after onset, diplopia at the primary 
position disappeared, and the best-corrected visual acuity in the 
right eye improved to 1.0 (Figure 3). Twenty weeks after onset, 
eye movements were almost completely recovered, except for 
abduction (Figure 4). However, the anisocoria still remained, 
despite the patient taking prednisolone 15 mg/day.
Discussion
Herpes zoster ophthalmicus can be triggered by reactivation 
of varicella zoster virus that is dormant in the trigeminal 
nerve ganglia. Reactivation of varicella zoster virus can be 
triggered by aging, an immunocompromised host, trauma, 
surgery, iatrogenic immunosuppression, tuberculosis, syphi-
lis, and radiation therapy. Half of herpes zoster ophthalmicus 
cases have ocular complications, including blepharitis, kera-
toconjunctivitis, iritis, scleritis, and acute retinal necrosis.3 
  Neurological complications, such as ophthalmoplegia and 
optic neuritis, are rare, but are responsive to antiviral or ste-
roid treatment. Ophthalmoplegia was found in 3.5%–10.1% 
of two large herpes zoster ophthalmicus series.3,4 Among the 
cases with extraocular nerve palsies, oculomotor nerve palsy 
is the most frequent and abducens nerve palsy the second 
most frequent.5,6
Several cases of orbital apex syndrome have been 
reported in association with more severe herpes zoster 
ophthalmicus.7–12 Shirato et al reported a 71-year-old man 
who developed orbital apex syndrome 12 days after onset 
of herpes zoster ophthalmicus.7 T1-weighted, gadolinium-
enhanced MRI showed diffuse enhancement of the orbital 
fat, ocular muscles, and optic nerve on the right side. They 
used systemic prednisolone 30 mg followed by tapering. 
Five months after the onset of herpes zoster ophthalmicus, 
the extraocular palsies and ptosis were slightly improved, 
but there was no improvement in visual acuity. Kattah and 
Kennerdell reported two cases of orbital apex syndrome 
associated with herpes zoster ophthalmicus.8 Both cases 
developed extraocular palsies and optic nerve dysfunction 
one and five days after onset of rash. After oral prednisolone 
80 mg, one of the patients recovered fully from the neu-
rological complications, and the other patient had an 
improvement in ophthalmoplegia and optic neuritis, but the 
left eye progressed to endophthalmitis followed by corneal 
perforation.
Krasnianski et al reported a case of orbital apex syndrome 
with complete ophthalmoplegia due to orbital myositis and 
optic neuritis two days after the onset of herpes zoster oph-
thalmicus.10 The case was a 67-year-old woman who was 
treated with acyclovir 750 mg for 10 days with prednisolone 
100 mg intravenously for three days, and then the predni-
solone was tapered. MRI with gadolinium enhancement 
showed marked thickening of all the external ocular muscles 
and optic nerve sheath on the right side. Four weeks later, 
the extraocular muscle palsies and optic neuritis recovered 
almost completely.
Bourke and Pyle reported a 63-year-old woman with 
herpes zoster ophthalmicus who developed complete ptosis, 
total ophthalmoplegia, and loss of visual acuity 10 days after 
the rash developed.11 Treatment consisted of intravenous 
Figure  2  Enhanced  fat-suppressed  T1-weighted  magnetic  resonance  images. 
(A  and  B)  before  steroid  therapy.  (C  and  D)  after  intravenous  prednisolone. 
(A and C) are horizontal sections. (B and D) rare coronal sections. Enhancement of 
the optic nerve sheath and orbital apex can be seen before treatment (arrows).
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methylprednisolone 500 mg/day for three days, followed 
by a two-week course of oral prednisolone reducing by 
80 mg/day. Oral acyclovir 800 mg every four hours was also 
used. The ocular movements slowly improved. The day fol-
lowing initiation of therapy, supraduction, infraduction, and 
incyclotorsion were slightly improved. Visual acuity also 
increased from finger counting to 6/24 on the next day, and 
further improved to 6/18 soon thereafter. At one year after 
onset, visual symptoms were completely resolved.
Dhingra et al9 reported a case of orbital apex syndrome 
associated with herpes zoster ophthalmicus and   multiple 
myeloma. The signs and symptoms of herpes zoster 
  ophthalmicus developed after the patient had completed 
  chemotherapy. Although systemic acyclovir and   prednisolone 
30 mg slightly improved the visual acuity and disturbances 
of eye movements, the ptosis, anisocoria, and partial oph-
thalmoplegia did not improve. Saxena et al12 also reported 
a case of human immunodeficiency virus associated with 
herpes zoster ophthalmicus. A 29-year-old woman developed 
severe anterior uveitis, optic neuritis, complete ptosis, and 
ophthalmoplegia due to myositis 14 days after the onset of 
a facial rash. Serological testing was positive for human 
immunodeficiency virus. Highly active antiretroviral therapy 
and oral acyclovir 800 mg five times a day were started. Five 
days later, oral prednisolone 1 mg/kg/day was combined with 
highly active antiretroviral therapy and acyclovir therapy. By 
the end of four weeks, visual acuity and extraocular motility 
were markedly improved.
In most of the earlier reports, and in our patient, orbital 
apex syndrome developed within 14 days of onset of herpes 
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Figure 3 Time course of ocular symptoms and signs after onset of orbital apex syndrome. After onset, the amount of steroid was increased from betamethasone 4 mg, and 
the converted amount of prednisolone was 26–60 mg. Ocular movement, visual acuity, and ptosis gradually improved thereafter. Vidarabine was also given for 12 days after 
the onset of orbital apex syndrome.
Abbreviations: OAS, orbital apex syndrome; DIV, intravenous injection by drip; BCVA, best-corrected visual acuity.
Figure 4 Photographs of eye positions in all directions five months after initiation of 
therapy. (A) Most ocular movements are markedly improved, except for abduction. 
Subconjunctival hemorrhage is present in the left eye. (B) Photograph of face one 
month after initiation of therapy. The skin lesions are almost resolved but ptosis 
remains.
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zoster ophthalmicus and was relatively responsive to steroid 
therapy, but may need more than 60 mg of prednisolone. The 
outcomes of visual function were good, although the duration 
of treatment may need to be from four weeks to one year.
Sanjay et al summarized the clinical characteristics and 
course of 20 well documented cases of herpes zoster ophthal-
micus presenting with complete ophthalmoplegia.13 Herpes 
zoster ophthalmicus preceded the ophthalmoplegia as orbital 
apex syndrome by a mean interval of 9.5 days. Sixty-five 
percent of these cases recovered completely or partially after 
antiviral and steroid therapy, although anisocoria remained 
in most cases, as in our patient. In consideration of our case 
and the earlier reports, combined antiviral and steroid therapy 
should be effective in cases of orbital apex syndrome if the 
steroid therapy is used for at least four months.
The pathological mechanism for ophthalmoplegia in 
cases of herpes zoster ophthalmicus has not been determined. 
Histopathological studies have demonstrated significant 
perivascular and perineural inflammation of the ocular tis-
sues, including the optic nerve, cavernous sinus, superior 
orbital fissure, and retina.14 Earlier histological studies on 
autopsy specimens have suggested two possible pathological 
mechanisms, ie, reactivation of varicella zoster virus in the 
trigeminal ganglion, which then invades the cavernous sinus 
and superior orbital fissure,5 and a second mechanism might 
be lymphocytic infiltration of the affected nerves by sensory 
offshoots of the trigeminal nerves to all the motor nerves 
of the eye.15 Naumann et al showed that inflammatory cells 
infiltrated the orbital apex along the long posterior ciliary 
vessels and nerves in 21 enucleated eyes affected by herpes 
zoster ophthalmicus, indicating that the neuropathy arises 
from an occlusive vasculitis.16 Thus, the ophthalmoplegia 
and optic neuritis are suggested to be due to direct invasion 
by varicella zoster virus or by an inflammatory reaction and 
occlusive vasculitis after virus invasion. Lexa et al reported 
a case of herpes zoster ophthalmicus with optic neuritis, total 
ophthalmoplegia, and cerebellar manifestations.14 Enhanced 
MRI showed enhancement around the optic nerve sheath, 
which corresponded with the post mortem findings of inva-
sion of inflammatory cells into the sheath of the optic nerve 
and ischemic changes in the optic nerve axons.
Cases of herpes zoster ophthalmicus with optic neuritis 
have been reported, and MRI and computed tomography 
show direct spread of granulomatous inflammation into 
the orbital apex.8,11 Immunohistological examination of an 
autopsy specimen in a case of human immunodeficiency virus 
infection showed direct invasion of varicella zoster virus into 
the retina and optic nerve.17
Our patient responded well to steroids and antiviral 
therapy, although the time needed to achieve significant 
resolution was more than five months. However, treatment 
for herpetic encephalopathy, with which our patient was 
initially diagnosed, might not have been long enough to 
improve symptoms. MRI findings showing enhancement of 
the optic nerve might reflect a direct inflammatory reaction 
rather than occlusive vasculitis.
In conclusion, herpes zoster ophthalmicus is a relatively 
common disease in clinical ophthalmological practice, but is 
rarely accompanied by neurological complications. Orbital 
apex syndrome should be considered among the more severe 
ocular complications of herpes zoster ophthalmicus. If com-
bined antiviral and steroid therapy is initiated early, it can 
be expected that visual dysfunction will recover. Therefore, 
ophthalmologists should be careful not to miss the neuro-
logical complications, and be especially vigilant during the 
14 days after onset of herpes zoster ophthalmicus.
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